Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Rosuvastatin Stories

2012-03-23 05:43:28

(Ivanhoe Newswire) — Researchers are trying to find the answers to cholesterol! In three phase 1 trials, they analyzed how PCSK9 binds to LDL receptors and will lead to their accelerated degradation and to increased LDL cholesterol levels. In 2003, a study was performed on two families with autosomal dominant hypercholesterolemia that is associated with gain-of-function mutations in PCSK9 (proprotein convertase subtilisin/kexin 9), one of the serine proteases. The patients involved...

2012-03-19 16:51:32

Statins may prevent pneumonia, according to a new study in CMAJ (Canadian Medical Association Journal). Researchers from Israel and the United States analyzed data from the JUPITER trial, a randomized, double-blind trial with placebo control groups conducted at 1315 sites in 26 countries to look at the use of the statin rosuvastatin in disease prevention. The trial involved 17 802 men aged 50 years or older and women aged 60 years or older without a history of heart disease or diabetes....

2012-03-19 02:25:42

SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2) Activity. The PLAC® Test for Lp-PLA(2) Activity is CE-marked for use outside of the United States and is an investigational assay in the United States. This test, which measures the pro-inflammatory...

2012-03-15 21:02:00

PITTSBURGH and TORONTO, March 15, 2012 /PRNewswire/ -- Mylan Pharmaceuticals ULC, the Canadian subsidiary of Mylan Inc. (NASDAQ: MYL), today received approval from Health Canada for Mylan-Rosuvastatin Calcium Tablets, 5mg, 10mg, 20mg and 40mg. Mylan-Rosuvastatin is the generic version of Astra Zeneca's Crestor® Tablets, which are used for the management of primary hypercholesterolaemia, mixed dyslipidaemia, and familial hypercholesterolaemia. According to IMS Health, Rosuvastatin Calcium...

2012-03-01 17:07:00

PHILADELPHIA, March 1, 2012 /PRNewswire/ -- Are statin drugs leading to more problems than just diabetes and memory loss as the FDA says? Following on the heels of the FDA announcing changes to the safety information on statin labels (e.g. Pfizer Inc's Lipitor, AstraZeneca's Crestor and Merck & Co's Zocor) concerning blood sugar and memory problems, a collection of consumer health groups, such as Natural Society, are raising public awareness about the hundreds of additional...

Diabetes, Memory Loss Warnings Added to Cholesterol Medications
2012-02-29 06:16:38

The U.S. Food and Drug Administration (FDA) announced on Tuesday that they would be adding memory loss and diabetes warnings to the labels of cholesterol-lowering drugs known as statins. According to Reuters reporters Bill Berkrot and Ransdell Pierson, the label changes come after the agency learned of studies in which taking statins could lead to a small increased risk of cognitive issues such as memory loss or confusion, as well as a slight spike in blood sugar levels and the risk of...

2012-02-13 05:30:00

MONTGOMERY, Ala., Feb. 13, 2012 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. today announced data assessing the effect of LIVALO® (pitavastatin) compared with Crestor® (rosuvastatin) on steady-state pharmacodynamics (PD) of warfarin by measuring international normalized ratio (INR) in healthy adult subjects.(1) The study, published in Current Medical Research & Opinion, showed INR during stable warfarin treatment did not change significantly when LIVALO was...

2012-02-02 04:40:00

LONDON, February 2, 2012 /PRNewswire/ -- AstraZeneca, the Anglo-Swedish pharmaceutical company, said that government price intervention had reduced its revenues by about $1bn as it announced further restructuring alongside its full-year results. In an interview on http://www.cantos.com, David Brennan, CEO, discusses AstraZeneca's portfolio performance including Brilinta and Crestor, and the prospects for the pipeline in light of recent disappointments. He also...

2011-12-27 15:45:00

The law firm of Hissey Kientz, LLP is announcing the launch of its new Crestor website, Crestor Side Effects Lawyers (http://www.crestorsideeffectslawyers.com/). Recent studies have linked Crestor to a number of serious and possibly deadly side effects, including cardiomyopathy, kidney problems and diabetes. Austin, Texas (PRWEB) December 27, 2011 The law firm of Hissey Kientz, LLP is announcing the launch of its new Crestor website, Crestor Side Effects Lawyers...

Cholesterol Drugs Equally Effective In Reducing Plaque
2011-11-15 13:32:45

A new study has found that Pfizer Inc.'s Lipitor and AstraZeneca's Crestor cholesterol drugs are both equally effective in treating coronary artery disease. Crestor caused a bigger drop in LDL cholesterol than Lipitor, but they both tied when it came to reducing plaque.  LDL cholesterol is the bad kind that can cause build-up of plaque inside the arteries. "The good thing is that these are both effective drugs," Stephen Nicholls, clinical director of the Cleveland Clinic Center for...